Clinical Trials Update: Sept. 10, 2004
Lung Cancer Ovarian Cancer Eczema (Atopic Dermatitis - Pediatric)
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A research study to measure the effects of an investigational medication on progression of lung cancer. Volunteers over age 18 who have a confirmed diagnosis of non-small cell lung cancer and who have not previously received chemotherapy as the primary treatment for lung cancer may be eligible. Research sites located throughout the United States.
A research study of an investigational medication for the treatment of ovarian cancer. Women 18 or older who have a diagnosis of epithelial cancer of the ovary, fallopian tube or primary peritoneal cancer and who have had progression after platinum-based chemotherapy or after therapy with Doxil/Caelyx or Hycamtin may be eligible. Research sites located throughout the United States.
Eczema (Atopic Dermatitis - Pediatric)
A research study of an investigational medication for children with eczema. Children between 3-18 months of age who have had eczema for less then three months, and who have a parent or sibling with a history of eczema, allergies, or asthma may be eligible. Research site located in Walnut Creek, Calif.
Copyright 2004 CenterWatch. All rights reserved.